Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

MonoSol Rx, BioDelivery Sciences trade accusations in lawsuit
Fierce Drug Delivery
Saturday, January 22, 2011 - 10:23am
tags:
MonoSol Rx, BioDelivery Sciences, lawsuits
First MS pill may be available soon (in the UK)
Press Assocation News
Saturday, January 22, 2011 - 10:18am
tags:
multiple sclerosis, Gilenya, Novartis
Biotech VC investing grows 3% in 2010
Fierce Biotech
Friday, January 21, 2011 - 12:32pm
tags:
biotech, venture capital
Pfizer, Merck ask court to keep patent deals secret
Fierce Pharma
Friday, January 21, 2011 - 12:29pm
tags:
Pfizer, patents, Merck
Can You Say No to Jiangbo?
Seeking Alpha
Friday, January 21, 2011 - 12:28pm
tags:
Jiangbo Pharmaceuticals, China
Despite Abbott Pullback, DepoMed Still a Value
Seeking Alpha
Friday, January 21, 2011 - 12:27pm
tags:
Abbott Laboratories, Depomed, DM-1796
Showdown time is coming for AZ's Crestor
Fierce Pharma
Friday, January 21, 2011 - 10:15am
tags:
AstraZeneca, Crestor, patents, generics
Acorda, Biogen fall on EU drug rejection
Marketwatch
Friday, January 21, 2011 - 10:13am
tags:
Acorda Therapeutics, Europe, Biogen Idec, Fampyra, MS, multiple sclerosis
Novartis MS Pill Wins European Backing as Rival Acorda Rejected
Bloomberg
Friday, January 21, 2011 - 10:11am
tags:
Novartis, MS, multiple sclerosis, Europe, Acorda Therapeutics, Gilenya, Merck KGaA
Vivus says FDA asks about Qnexa birth defect link
Yahoo/AP
Friday, January 21, 2011 - 10:10am
tags:
Qnexa, birth defects, FDA, Vivus, obesity
Merck Faces First State Trial on Fosamax
TheStreet.com
Friday, January 21, 2011 - 9:24am
tags:
Fosamax, Merck, osteoporosis
Pfizer Extends Tender Offer to Acquire King Pharmaceuticals, Inc. to January 28, 2011
Yahoo
Friday, January 21, 2011 - 9:20am
tags:
Pfizer, King, tender offer, M&A
Major Drugmaker Sales Growth to Slow to 1.3%, Datamonitor Says
Bloomberg
Friday, January 21, 2011 - 8:00am
tags:
Bayer, Novartis, Roche, GSK, drug sales
Good News for Aastrom Bio: IMPACT-DCM Trials Show Proof-of-Concept
Seeking Alpha
Friday, January 21, 2011 - 7:59am
tags:
Aastrom, IMPACT-DCM
Are You Watching This Trend at Talecris Biotherapeutics?
Motley Fool
Friday, January 21, 2011 - 7:58am
tags:
Talecris
Why Big Pharma Is the New Big Biotech
Seeking Alpha
Friday, January 21, 2011 - 7:57am
tags:
Big Pharma, Amgen, Celgene, Gilead Sciences, Roche
AstraZeneca Replies to FDA’s Decision on Brilinta
Bloomberg
Friday, January 21, 2011 - 7:55am
tags:
Brilinta, FDA, AstraZeneca, blood thinners
Defending Merck’s CEO
Forbes
Friday, January 21, 2011 - 7:54am
tags:
Merck, Pharma CEOs, Kenneth Frazier, Vorapaxar
Lilly Fails to Win Panel’s Backing for Imaging Drug
Bloomberg
Thursday, January 20, 2011 - 6:37pm
tags:
Eli Lilly, imaging, FDA, advisory panels, Amyvid, Alzheimer's disease
Here's How King Pharmaceuticals May Be Failing You
Motley Fool
Thursday, January 20, 2011 - 6:35pm
tags:
King, Pfizer, Eli Lilly, Novartis, Teva Pharmaceuticals

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.